当2019冠状病毒病(COVID-19)肺炎还不够时:罕见的细菌合并感染病例

B. Anderson, A. Nathani, S. Ghamande
{"title":"当2019冠状病毒病(COVID-19)肺炎还不够时:罕见的细菌合并感染病例","authors":"B. Anderson, A. Nathani, S. Ghamande","doi":"10.1164/AJRCCM-CONFERENCE.2021.203.1_MEETINGABSTRACTS.A4093","DOIUrl":null,"url":null,"abstract":"Introduction: Atypical bacterial coinfections, including more rare organisms such as Legionella pneumophila, can complicate coronavirus disease 2019 (COVID-19) infections. Care should be taken to avoid anchoring bias and ensure all bacterial coinfections are diagnosed and treated in patients with COVID-19. CASE REPORT: A 49-year-old male with no past medical history developed abdominal pain, diarrhea and cough on April 4, 2020. He tested positive for SARS-CoV 2 on April 6th given there were several people at his work that had recently contracted coronavirus disease 2019 (COVID-19). Over the next week he developed progressive fever, cough, anosmia, ageusia and then dyspnea with exertion which prompted him to seek medical care. Shortly after admission, he became more febrile, tachycardic and hypoxic requiring oxygen supplementation via high-flow nasal cannula. His oxygen requirements continued to worsen, and he was transferred to the ICU and intubated. His procalcitonin was elevated at 8.99 and he was started on empiric broad spectrum antibiotics. Tracheal aspirate was tested via PCR and returned positive for Legionella pneumophila. He also tested positive for Legionella urinary antigen. He received hydroxychloroquine for 7 days, IV doxycycline for 10 days, ceftriaxone for 6 days and piperacillin-tazobactam for 2 days. He gradually improved and was successfully weaned off supplemental oxygen. He was discharged after a 10-day hospital stay with minimal respiratory symptoms. DISCUSSION: Among patients diagnosed with COVID-19, Legionella bacterial coinfection appears to be rare. In a systematic review published in July 2020, Rawson et al reported that only 8% (62/806) of patients diagnosed with COVID-19 were diagnosed with a bacterial pneumonia coinfection and found only one patient who had COVID-19 and Legionella. However, it has been reported that there may be an increased risk of Legionella infections during the COVID-19 pandemic due to water systems being used less often because of lockdown orders. In September 2020, De Giglio et al reported that a large Italian hospital found a significant increase in Legionella pneumophila isolates on routine water system testing in two of three wards which had been closed for over a month due to emergency reorganization. It remains important to keep Legionella bacterial co-infection on the differential when treating COVID-19 since it may require a longer treatment regimen than what is recommended for treating standard community acquired pneumonia. In addition, the pandemic response has the potential to increase the risk of legionella infections secondary to stagnant water systems in lockdowns.","PeriodicalId":23169,"journal":{"name":"TP100. TP100 UNEXPECTED COVID-19 CASE REPORTS","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"When Coronavirus Disease 2019 (COVID-19) Pneumonia Isn't Enough: A Rare Case of Bacterial Coinfection\",\"authors\":\"B. Anderson, A. Nathani, S. Ghamande\",\"doi\":\"10.1164/AJRCCM-CONFERENCE.2021.203.1_MEETINGABSTRACTS.A4093\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Atypical bacterial coinfections, including more rare organisms such as Legionella pneumophila, can complicate coronavirus disease 2019 (COVID-19) infections. Care should be taken to avoid anchoring bias and ensure all bacterial coinfections are diagnosed and treated in patients with COVID-19. CASE REPORT: A 49-year-old male with no past medical history developed abdominal pain, diarrhea and cough on April 4, 2020. He tested positive for SARS-CoV 2 on April 6th given there were several people at his work that had recently contracted coronavirus disease 2019 (COVID-19). Over the next week he developed progressive fever, cough, anosmia, ageusia and then dyspnea with exertion which prompted him to seek medical care. Shortly after admission, he became more febrile, tachycardic and hypoxic requiring oxygen supplementation via high-flow nasal cannula. His oxygen requirements continued to worsen, and he was transferred to the ICU and intubated. His procalcitonin was elevated at 8.99 and he was started on empiric broad spectrum antibiotics. Tracheal aspirate was tested via PCR and returned positive for Legionella pneumophila. He also tested positive for Legionella urinary antigen. He received hydroxychloroquine for 7 days, IV doxycycline for 10 days, ceftriaxone for 6 days and piperacillin-tazobactam for 2 days. He gradually improved and was successfully weaned off supplemental oxygen. He was discharged after a 10-day hospital stay with minimal respiratory symptoms. DISCUSSION: Among patients diagnosed with COVID-19, Legionella bacterial coinfection appears to be rare. In a systematic review published in July 2020, Rawson et al reported that only 8% (62/806) of patients diagnosed with COVID-19 were diagnosed with a bacterial pneumonia coinfection and found only one patient who had COVID-19 and Legionella. However, it has been reported that there may be an increased risk of Legionella infections during the COVID-19 pandemic due to water systems being used less often because of lockdown orders. In September 2020, De Giglio et al reported that a large Italian hospital found a significant increase in Legionella pneumophila isolates on routine water system testing in two of three wards which had been closed for over a month due to emergency reorganization. It remains important to keep Legionella bacterial co-infection on the differential when treating COVID-19 since it may require a longer treatment regimen than what is recommended for treating standard community acquired pneumonia. In addition, the pandemic response has the potential to increase the risk of legionella infections secondary to stagnant water systems in lockdowns.\",\"PeriodicalId\":23169,\"journal\":{\"name\":\"TP100. TP100 UNEXPECTED COVID-19 CASE REPORTS\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"TP100. TP100 UNEXPECTED COVID-19 CASE REPORTS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/AJRCCM-CONFERENCE.2021.203.1_MEETINGABSTRACTS.A4093\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"TP100. TP100 UNEXPECTED COVID-19 CASE REPORTS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/AJRCCM-CONFERENCE.2021.203.1_MEETINGABSTRACTS.A4093","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

非典型细菌共感染,包括更罕见的细菌,如嗜肺军团菌,可使2019冠状病毒病(COVID-19)感染复杂化。应注意避免锚定偏差,并确保对COVID-19患者的所有细菌合并感染进行诊断和治疗。病例报告:一名49岁男性,无既往病史,于2020年4月4日出现腹痛、腹泻和咳嗽。鉴于他工作的几个人最近感染了2019冠状病毒病(COVID-19),他在4月6日的SARS-CoV检测呈阳性。在接下来的一个星期里,他出现了进行性发烧、咳嗽、嗅觉丧失、失语,然后是用力时呼吸困难,这促使他去看医生。入院后不久,患者出现发热、心动过速和缺氧,需要通过高流量鼻插管补充氧气。他的氧气需求继续恶化,他被转移到重症监护室并插管。他的降钙素原升高到8.99,他开始使用广谱抗生素。经PCR检测气管抽吸结果为嗜肺军团菌阳性。他的军团菌尿抗原检测也呈阳性。羟氯喹7天,强力霉素10天,头孢曲松6天,哌拉西林-他唑巴坦2天。他逐渐好转,并成功地停止了补充氧气。他在住院10天后出院,呼吸道症状很轻。讨论:在诊断为COVID-19的患者中,军团菌合并感染似乎很罕见。在2020年7月发表的一篇系统综述中,Rawson等人报告说,在被诊断为COVID-19的患者中,只有8%(62/806)被诊断为细菌性肺炎合并感染,只有1名患者同时患有COVID-19和军团菌。然而,据报道,在2019冠状病毒病大流行期间,由于封锁令导致供水系统的使用频率降低,军团菌感染的风险可能会增加。2020年9月,De Giglio等人报告称,意大利一家大型医院因紧急重组而关闭了一个多月的三个病房中,有两个病房在常规水系统检测中发现嗜肺军团菌分离株显著增加。在治疗COVID-19时,保持军团菌合并感染的区别仍然很重要,因为它可能需要比治疗标准社区获得性肺炎推荐的治疗方案更长的治疗方案。此外,大流行应对有可能增加军团菌感染的风险,继发于封锁期间的死水系统。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
When Coronavirus Disease 2019 (COVID-19) Pneumonia Isn't Enough: A Rare Case of Bacterial Coinfection
Introduction: Atypical bacterial coinfections, including more rare organisms such as Legionella pneumophila, can complicate coronavirus disease 2019 (COVID-19) infections. Care should be taken to avoid anchoring bias and ensure all bacterial coinfections are diagnosed and treated in patients with COVID-19. CASE REPORT: A 49-year-old male with no past medical history developed abdominal pain, diarrhea and cough on April 4, 2020. He tested positive for SARS-CoV 2 on April 6th given there were several people at his work that had recently contracted coronavirus disease 2019 (COVID-19). Over the next week he developed progressive fever, cough, anosmia, ageusia and then dyspnea with exertion which prompted him to seek medical care. Shortly after admission, he became more febrile, tachycardic and hypoxic requiring oxygen supplementation via high-flow nasal cannula. His oxygen requirements continued to worsen, and he was transferred to the ICU and intubated. His procalcitonin was elevated at 8.99 and he was started on empiric broad spectrum antibiotics. Tracheal aspirate was tested via PCR and returned positive for Legionella pneumophila. He also tested positive for Legionella urinary antigen. He received hydroxychloroquine for 7 days, IV doxycycline for 10 days, ceftriaxone for 6 days and piperacillin-tazobactam for 2 days. He gradually improved and was successfully weaned off supplemental oxygen. He was discharged after a 10-day hospital stay with minimal respiratory symptoms. DISCUSSION: Among patients diagnosed with COVID-19, Legionella bacterial coinfection appears to be rare. In a systematic review published in July 2020, Rawson et al reported that only 8% (62/806) of patients diagnosed with COVID-19 were diagnosed with a bacterial pneumonia coinfection and found only one patient who had COVID-19 and Legionella. However, it has been reported that there may be an increased risk of Legionella infections during the COVID-19 pandemic due to water systems being used less often because of lockdown orders. In September 2020, De Giglio et al reported that a large Italian hospital found a significant increase in Legionella pneumophila isolates on routine water system testing in two of three wards which had been closed for over a month due to emergency reorganization. It remains important to keep Legionella bacterial co-infection on the differential when treating COVID-19 since it may require a longer treatment regimen than what is recommended for treating standard community acquired pneumonia. In addition, the pandemic response has the potential to increase the risk of legionella infections secondary to stagnant water systems in lockdowns.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信